Mark Pizzurro, MD
Adult Reconstructive Orthopaedic Surgery · Ridgewood, NJNPI 1952505398
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $227,781 of the $239,056 with a category attached, or 95.3%. Stryker accounts for 99.4% of it on its own, with 11 other manufacturers making up the rest.
Across 284 payments — averaging $841.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$238K
- Seapearl East, Inc$645
- Johnson & Johnson$189
- Davol Inc.$162
- Sanara Medtech Inc.$125
- Kerecis Limited$56
- plus $171 from 6 others
What the payments were for
- Consulting fees$227,78195%
- Travel & lodging$4,7882%
- Food & beverage$6,4873%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 264 | $237,708 |
| Seapearl East, Inc | 2 | $645 |
| Johnson & Johnson | 8 | $189 |
| Davol Inc. | 2 | $162 |
| Sanara Medtech Inc. | 1 | $125 |
| Kerecis Limited | 1 | $56 |
| BD | 1 | $45 |
| Solventum Corporation | 1 | $40 |
| Integra Lifesciences Corporation | 1 | $26 |
| Axogen | 1 | $25 |
| Smith+Nephew | 1 | $22 |
| Bioventus LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$204,226
- TRIATHLON$23,867
- ACCOLADE$20,152
- INSIGNIA$8,865
- AEQUALIS$7,200
- RESTORATION$6,188
- TRITANIUM$5,288
- INSTRIDE$3,713
- TRIDENT$1,899
- REUNION$1,688
- PERFORMANCE-LOAD$1,350
- GMRS$563
- NONE$153
- PERFORMANCE SOLUTIONS$150
- ADAPT$144
- Surgiphor$136
- CellerateRx$125
How this compares
$239,056 in reported general payments places this provider in the 85th percentile of 39 adult reconstructive orthopaedic surgery providers in New Jersey.
See all adult reconstructive orthopaedic surgery providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 86 | $1,594 |
| Meloxicam | 126 | $349 |
| Amoxicillin | 147 | $327 |
| Clindamycin Hcl | 24 | $127 |
| Methylprednisolone | 23 | $108 |
| Tramadol Hcl | 28 | $69 |
| Prednisone | 17 | $61 |
| Cyclobenzaprine Hcl | 11 | $54 |
| Gabapentin | 12 | $29 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Ridgewood
- Ismar DizdarevicRidgewood$368K
- Atul KamathManasquan$4M
- Alfred TriaSomerset$582K
- John DundonHackettstown$573K
- David FeldmanEnglewood$335K
- Jeffrey LearyNew Providence$148K
- Timothy HendersonWayne$140K
- Anthony CostaEatontown$95K
- Gregory RoehrigManasquan$75K
- Brian PerezCedar Knolls$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.